TLR9 and cervical carcinoma: For example, a transcriptional inhibitory chromatin modification complex composed of the estrogen receptor alpha (ERα), HDAC1, JARID1B, and NF-kB transcription factor represses the expression of toll-like receptor 9 (TLR9) in the presence of E7 oncoprotein in cervical cancer cells [14].